Practical Information for Today's Pharmacist
A clinical trial of tivozanib with nivolumab for renal cell carcinoma did not meet its primary endpoint of progression-free survival, but the tivozanib monotherapy arm provided clinically meaningful data.
Read more here:
There were positive efficacy and safety results for tivozanib monotherapy consistent with previous analyses.
A study suggests that combining the Mediterranean diet with omega-3 supplements may improve acne severity.
Read more here:
Individuals that followed the Mediterranean diet with EPA-DHA supplements displayed an increase in omega-3 levels which improved clinical appearance.
Pharmacogenomics testing for tacrolimus dosing in kidney transplant recipients can be cost-effective despite upfront costs, potentially reducing hospitalization rates and improving quality of life.
Read more:
More cost effectiveness data is crucial in advocating for better insurance coverage in the United States.
A study suggests that nonprescription sunscreens can help protect against skin damage from excessive sun exposure.
Read more:
The importance of protecting the skin is often underestimated by patients
A study suggests patients with mantle cell lymphoma have a high risk of infections before, during, and after treatment.
Read more:
In a study of Swedish patients with mantle cell lymphoma, the participants faced a heightened risk of infection after their diagnosis and associated treatment for the disease.
A meta-analysis suggests that pharmacists can significantly reduce blood pressure, potentially improving patient outcomes through increased involvement in blood pressure management.
Read more:
The findings showed that pharmacist-led interventions resulted in the greatest systolic blood pressure reductions.
A cellular therapy called Lomecel-B is being investigated as a treatment for Alzheimer's disease in a phase 2a clinical trial called CLEARMIND.
Learn more:
Safety and efficacy findings on Lomecel-B will be presented at the upcoming 2024 Alzheimer’s Association International Conference, which will be held July 28 to August 1.
ROUNDTABLE: Experts discuss the advantages of utilizing single-dose prefilled syringes in opioid treatment, though they agreed that flexibility and a multidisciplinary approach to product selection are essential.
Watch the discussion:
A panel of experts analyze the impact of prefilled syringes on workflows across diverse patient populations, emphasizing cost savings, patient safety, and interdisciplinary collaboration.
Recognizing and managing comorbidities like allergic rhinitis, food allergy, and anaphylaxis is important to improve asthma control in children.
Read more here:
The authors emphasize that clinical research should focus on real-world difficulties, and pediatric asthma control should be seen as a health care priority.
NEWS: CrowdStrike experienced a global outage this morning, disrupting services at hospitals, banks, and other businesses. The problem has been fixed, but it may take some time for disruptions to end.
Read our coverage here:
The cause of the outage was deemed to be due to a defect found in a content update for Windows users.
A new study suggests that a decrease in the brain chemical acetylcholine (ACh) might contribute to anorexia nervosa, and that drugs that prevent the breakdown of ACh could be a potential new treatment.
Read more here:
Acetylcholine deficit observed in patients with anorexia nervosa suggest potential targeted treatment options.
VIDEO: A panel of experts discuss the challenges with responsible opioid prescribing and emphasize a holistic care model, recommending active listening and interdisciplinary collaboration to overcome these obstacles.
Watch the episode here:
A panel of experts share insights on overcoming challenges in responsible opioid prescribing and explore emotional responses, aversion to change, and the role of interdisciplinary collaboration in addressing the opioid crisis.
Pembrolizumab combined with radiotherapy shows promise as a treatment for patients with relapsed or refractory multiple myeloma, according to a clinical trial.
Read more here:
Radiotherapy may have applications beyond symptomatic relief when used in combination with immunotherapy.
The risk of developing long Covid decreased as the first year of infection progressed and was reduced even after further following vaccination, with annual vaccinations encouraged for continued and sustained protection.
Read more here:
Investigators found that the risk of long COVID decreased over the course of the pandemic.
FDA News: Vonoprazan (Voquezna; Phantom Pharmaceuticals) has been approved for the treatment of heartburn associated with non-erosive gastroesophageal reflux disease in adults.
Learn more here:
A large portion of the population of patients in the United States with GERD have the non-erosive type of the disease.
A study finds that monitoring outpatient adverse drug events is crucial for improved prevention and mitigation strategies.
Read more here:
Currently, limited data show the effect of adverse drug events in the outpatient setting.
Check out the latest issue of Pharmacy Practice in Focus: Oncology for recaps on key data and findings for oncology practice presented at ASCO, and so much more! https://ow.ly/tWhn50SEwbb
ROUNDTABLE: Experts discuss the pivotal role of data and technology in effective opioid stewardship programs, noting that they can help address the challenges of health care professionals regarding effective patient care.
Watch the episode here:
Experts explore using technology and data analytics to enhance opioid stewardship programs, addressing challenges health care professionals face, and providing strategies for effective patient care, leveraging data, and fostering supportive environments.
A study suggests a possible link between semaglutide and nonarthritic anterior ischemic optic neuropathy, but further investigation is needed to confirm a causal relationship.
Read more:
Use of semaglutide injections may be linked to an increased risk of blindness in patients with diabetes.
A new model that uses genetic sequencing may help predict taxane-related nerve damage in breast cancer survivors.
Read more:
Prediction model can accurately predict the risk of nerve damage in patients who received taxane-based chemotherapy.
High-dose eicosatetraenoic acid (EPA) and docosahexaenoic acid (DHA) supplementation shows promise as a first-choice treatment for migraine prophylaxis, but more research is needed.
Read more:
In a meta-analysis, high-dose eicosatetraenoic acid and docosahexaenoic acid had the highest efficacy and lowest dropout rate among pharmacological interventions for migraine.
What do you find most rewarding each day?
The G900 region, near the GATA3 gene, may be a target for future asthma therapies as it plays a significant role in allergic airway inflammation.
Read more:
The findings demonstrate that the mG900 region plays a significant role in Type-2 helper T (Th2) cell differentiation and enhances allergic airway inflammation.
VIDEO: Allison Burns, president & CEO of EMO Health, discusses how OTC naloxone could help reduce stigma and increase access, potentially reducing opioid overdose deaths.
Watch the interview here:
Allison Burns, president and CEO of EMO Health, discusses the price point and stigma surrounding OTC naloxone in an interview with Pharmacy Times.
The biosimilar adalimumab is the most cost-effective treatment for rheumatoid arthritis after methotrexate failure, according to a study.
Read more:
After failure with methotrexate, treatment with leflunomide is typically recommended, but treatment with biosimilars could have greater quality-adjusted life years.
A study suggests wearable devices can effectively monitor treatment response in patients with heart failure and atrial fibrillation.
Read more:
Consumer-wearable devices can monitor treatment response and provide continuous health data for patients with heart disease and atrial fibrillation.
New therapies like erdafitinib, avelumab, pembrolizumab, and enfortumab vedotin-efjv are emerging for the systemic treatment of metastatic urothelial cancer after platinum-based chemotherapy.
Read more:
Treatment of advanced/metastatic urothelial cancer has changed dramatically in recent years. This review discusses the use, risks, and benefits of several novel therapies for this indication.
RSV can cause serious illness in adults, and pharmacists must not underestimate the key role they have in recommending vaccination for patients.
Read more:
Pharmacists’ awareness of respiratory syncytial virus and their role in educating about the vaccine have grown dramatically.
Ni****ne replacement therapy, available in patches, gum, lozenges, and more, can help people overcome cravings and quit smoking with the support of pharmacists. ****ne
Read more:
Helping patients overcome barriers to accessing these treatments is a vital role for pharmacists, who can support patients who are looking to quit.
Prioritizing research and education on women's heart health could improve health outcomes and generate substantial economic benefit, according to a new report.
Read more:
Increased awareness of women's cardiovascular health and the impact of estrogen fluctuation throughout women’s lives on cardiovascular disease could both boost the economy and improve health outcomes.
NJ
Be the first to know and let us send you an email when Pharmacy Times posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Check out the latest issue of Pharmacy Practice in Focus: Oncology for recaps on key data and findings for oncology practice presented at ASCO, and so much more! https://ow.ly/tWhn50SEwbb
Is your knowledge up-to-date with the top-recommended OTC products? The 2024-2025 OTC Guide®, recommended by your trusted pharmacists, features the best OTC products across hundreds of categories. Explore this year's expert picks for your everyday health needs! Find out more: https://bit.ly/3XrJUn9.
Happy Independence Day from all of us at Pharmacy Times®! Thank you for your dedication to ensuring the well-being of our nation. We wish you a day filled with endless celebration and happiness. 🎇🤍 #Pharmacy #4thofJuly #IndependenceDay
Check out the latest issue of Pharmacy Practice in Focus: Oncology for peer reviewed content on CLL, drug shortages in community pharmacy, reducing observation time for patients with multiple myeloma, and so much more! https://ow.ly/Nl3c50SmL1H
Inclusivity is at the heart of Pharmacy Times' 127-year legacy. This Pride Month, we reaffirm our commitment to championing LGBTQ+ pharmacists and creating spaces for diverse voices to be seen, heard and celebrated within our industry.
Today is #WorldHypertensionDay! According to WHO, approximately 1.28 billion people aged 30 to 79 years have #hypertension, a major risk factor for heart disease, stroke, & death. Pharmacists can play a key role in screening, education & blood pressure screening. Read More: https://bit.ly/4bJeqg6
Check out the latest issue of Pharmacy Practice in Focus: Health Systems for peer-reviewed content on how a pharmacist-led transitions of care program reduced COPD readmissions, how AI can improve treatment adherence, and so much more: https://bit.ly/3yc9CBt
At Pharmacy Times®, we recognize the importance of Mental Health Awareness Month. We are dedicated to supporting our community and extending our advocation for wellness this May and all year round. #MentalHealthMatters #MentalHealthAwarenessMonth
Want your business to be the top-listed Media Company?
